158 related articles for article (PubMed ID: 17584925)
1. Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats.
Otto J; Jansen PL; Lucas S; Schumpelick V; Jansen M
BMC Cancer; 2007 Jun; 7():104. PubMed ID: 17584925
[TBL] [Abstract][Full Text] [Related]
2. Phospholipids reduce the intraperitoneal adhesion of colonic tumor cells in rats and adhesion on extracellular matrix in vitro.
Jansen M; Treutner KH; Jansen PL; Otto J; Schmitz B; Mueller S; Weiss C; Tietze L; Schumpelick V
Int J Colorectal Dis; 2004 Nov; 19(6):525-32. PubMed ID: 15309464
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of gastric cancer cell adhesion in nude mice by inraperitoneal phospholipids.
Jansen M; Treutner KH; Jansen PL; Zuber S; Otto J; Tietze L; Schumpelick V
World J Surg; 2005 Jun; 29(6):708-14. PubMed ID: 15895297
[TBL] [Abstract][Full Text] [Related]
4. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
5. [Experimental chemotherapy of peritoneal carcinomatosis of colonic origin in rats].
Chauffert B; Dimanche-Boitrel MT; Genne P; Petit JM; Onier N; Jeannin JF
Gastroenterol Clin Biol; 1992; 16(3):215-9. PubMed ID: 1582536
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal treatment using taxol is effective for experimental peritoneal carcinomatosis in a rat model.
Hribaschek A; Ridwelski K; Pross M; Meyer F; Kuhn R; Halangk W; Boltze C; Lippert H
Oncol Rep; 2003; 10(6):1793-8. PubMed ID: 14534698
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis.
Hribaschek A; Meyer F; Schneider-Stock R; Pross M; Ridwelski K; Lippert H
Chemotherapy; 2007; 53(6):410-7. PubMed ID: 17952000
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin for chemotherapeutic treatment and prevention of experimental peritoneal carcinomatosis in rats comparing the intraperitoneal and intravenous application mode.
Hribaschek A; Meyer F; Ridwelski K; Kuester D; Lippert H
Eur Surg Res; 2010; 44(2):74-81. PubMed ID: 20051689
[TBL] [Abstract][Full Text] [Related]
9. Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.
Bobrich E; Braumann C; Opitz I; Menenakos C; Kristiansen G; Jacobi CA
J Surg Res; 2007 Jan; 137(1):75-82. PubMed ID: 17109891
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice.
Shimada T; Nomura M; Yokogawa K; Endo Y; Sasaki T; Miyamoto K; Yonemura Y
J Pharm Pharmacol; 2005 Feb; 57(2):177-81. PubMed ID: 15720780
[TBL] [Abstract][Full Text] [Related]
11. Treatment with endotoxins of peritoneal carcinomatosis induced by colon tumor cells in the rat.
Lagadec P; Jeannin JF; Reisser D; Pelletier H; Olsson O
Invasion Metastasis; 1987; 7(2):83-95. PubMed ID: 3583623
[TBL] [Abstract][Full Text] [Related]
12. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
[TBL] [Abstract][Full Text] [Related]
13. Effect of intraperitoneal chemotherapy and fibrinolytic therapy on tumor implantation in wound sites.
Jacquet P; Stuart OA; Dalton R; Chang D; Sugarbaker PH
J Surg Oncol; 1996 Jun; 62(2):128-34. PubMed ID: 8649039
[TBL] [Abstract][Full Text] [Related]
14. Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude mice.
Favoulet P; Benoit L; Osmak L; Polycarpe E; Esquis P; Duvillard C; Guiu B; Rat P; Favre JP; Chauffert B
World J Surg; 2004 May; 28(5):451-6. PubMed ID: 15085402
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis.
Koppe MJ; Hendriks T; Boerman OC; Oyen WJ; Bleichrodt RP
J Nucl Med; 2006 Nov; 47(11):1867-74. PubMed ID: 17079821
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver micrometastases.
Archer S; Gray B
Surgery; 1990 Sep; 108(3):502-7. PubMed ID: 2396194
[TBL] [Abstract][Full Text] [Related]
17. The development of a novel intraperitoneal tumor-seeding prophylactic.
Demetrick JS; Liggins RT; Machan L; Davis NL; Burt HM; Hunter WL
Am J Surg; 1997 May; 173(5):403-6. PubMed ID: 9168076
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of tumor cell adhesion on human mesothelial cells (HOMC) by phospholipids in vitro.
Jansen M; Jansen PL; Otto J; Kirtil T; Neuss S; Treutner KH; Schumpelick V
Langenbecks Arch Surg; 2006 Apr; 391(2):96-101. PubMed ID: 16534652
[TBL] [Abstract][Full Text] [Related]
19. Phospholipids reduce gastric cancer cell adhesion to extracellular matrix in vitro.
Jansen M; Treutner KH; Schmitz B; Otto J; Jansen PL; Neuss S; Schumpelick V
BMC Gastroenterol; 2004 Dec; 4():33. PubMed ID: 15625005
[TBL] [Abstract][Full Text] [Related]
20. Metastatic pattern of CC531 colon carcinoma cells in the abdominal cavity: an experimental model of peritoneal carcinomatosis in rats.
Lopes Cardozo AM; Gupta A; Koppe MJ; Meijer S; van Leeuwen PA; Beelen RJ; Bleichrodt RP
Eur J Surg Oncol; 2001 Jun; 27(4):359-63. PubMed ID: 11417980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
